Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEPCIDANE: Hepcidin Quantitation for Iron Deficiency Diagnosis in ICU
NCT02276690Completed
- Sponsor
- CHU Montpellier
- Start
- Aug 2014
- Primary completion
- Oct 2016
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by CHU Montpellier. Primary endpoint: Hospital cost. Started Aug 2014; status: completed.
Beyond the preview
Go deeper on NCT02276690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02276690.